Recent Progress of the Use of Interventional Therapy for Chronic Total Occlusion

다국어 초록 (Multilingual Abstract)

Chronic total occlusion (CTO) remains one of the most challenging lesion subsets for interventional cardiologists
due to a low success rate and higher incidence of restenosis, especially with current use of bare metal stents (BMSs).
However, successful CTO revascularization has a beneficial effect on long-term survival and relief of angina. With
recent advances in technology (with the use of special techniques and devices), the initial success rate of recanalization
of occlusions is quite high (approximately 90%). However, the long-term clinical outcome of the use of bare
metal stents is not satisfactory due to a high restenosis rate. Recently, the introduction of the sirolimus-eluting
stent (SES) and paclitaxel-eluting stent (PES) has shown favorable clinical outcomes, such as a reduction in the
restenosis rate in patients with CTOs. Consequently, the use of the new types of stents can reduce the incidence
of major adverse cardiac events detected at follow-up.

다국어 초록 (Multilingual Abstract)

Chronic total occlusion (CTO) remains one of the most challenging lesion subsets for interventional cardiologists
due to a low success rate and higher incidence of restenosis, especially with current use of bare metal stents (BMSs).
However, successful CTO revascularization has a beneficial effect on long-term survival and relief of angina. With
recent advances in technology (with the use of special techniques and devices), the initial success rate of recanalization
of occlusions is quite high (approximately 90%). However, the long-term clinical outcome of the use of bare
metal stents is not satisfactory due to a high restenosis rate. Recently, the introduction of the sirolimus-eluting
stent (SES) and paclitaxel-eluting stent (PES) has shown favorable clinical outcomes, such as a reduction in the
restenosis rate in patients with CTOs. Consequently, the use of the new types of stents can reduce the incidence
of major adverse cardiac events detected at follow-up.

참고문헌 (Reference)

1 Lotan C, "Stents in total occlusion for restenosis prevention: the multicentre randomized STOP study" 21 : 1960-1966, 2000

2 Sirnes PA, "Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty" 28 : 1444-1451, 1996

3 Sievert H, "Stent or angioplasty after recanalization of chronic coronary occlusions?" 84 : 386-390, 1999

4 Rubartelli P, "Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial" 32 : 90-96, 1998

5 Hoye A, "Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions" 43 : 1954-1958, 2004

6 Hancock J, "Randomized trial of elective stenting after successful percutaneous transluminal coronary angioplasty of occluded coronary arteries" 79 : 18-23, 1998

7 Buller CE, "Primary stenting versus balloon angioplasty in occluded coronary arteries" 100 : 236-242, 1999

8 Suttorp MJ, "Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions" 114 : 921-928, 2006

9 Buellesfeld L, "Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry" 66 : 173-177, 2005

10 Degertekin M, "Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up" 106 : 1610-1613, 2002

11 Werner G, "Paclitaxel-eluting stents for the treatment of chronic total occlusions: a strategy of extensive lesion coverage with drug-eluting stents" 67 : 1-9, 2006

12 Surmely JF, "New concept for CTO recanalization using a controlled antegrade and retrograde subintimal tracking: the CART technique" 18 : 334-338, 2006

13 Violaris AG, "Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions:a quantitative angiographic analysis" 91 : 2140-2150, 1995

14 Bell MR, "Initial and long-term outcome of 354 patients after coronary balloon angioplasty of total coronary occlusions" 85 : 1003-1011, 1992

15 Nakamura S, "Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions" 95 : 161-166, 2005

16 Olivari Z, "Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions" 41 : 1672-1678, 2003

17 Migliorini A, "Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion" 67 : 344-348, 2006

18 Surmely JF, "Coronary septal collaterals as an access for the retrograde approach in the percutaneous treatment of coronary chronic total occlusion" 69 : 826-832, 2007

19 Rensing BJ, "Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up" 22 : 2125-2130, 2001

20 Jang JS, "Comparison between sirolimusand paclitaxel-eluting stents for the treatment of chronic total occlusions" 18 : 205-208, 2006

21 Heyder M, "Angioplasty of chronic coronary artery occlusions: effect on clinical symptoms and left ventricular function" 85 : 125-132, 1996

22 Hoher M, "A randomized trial of elective stenting after balloon recanalization of chronic total occlusions" 34 : 722-729, 1999

23 Lefevre T, "A randomized study comparing two guide wire strategies for angioplasty of chronic total coronary occlusion" 85 : 1144-1147, 2000

24 Morice MC, "A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization" 346 : 1773-1780, 2002